Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Pediatric Rheumatology
Published in: Pediatric Rheumatology 1/2013

Open Access 01-11-2013 | Meeting abstract

PW01-009 – Markers of inflammation in adult FMF patients

Authors: A Giese, H Wittkowski, A Örnek, M Kurucay, E Lainka, BF Henning

Published in: Pediatric Rheumatology | Special Issue 1/2013

Login to get access

Excerpt

The therapeutic goal in Familial Mediterranean Fever (FMF) is to prevent attacks of clinically overt disease as well as to stop or reverse the development of amyloidosis and subsequent organ damage. The dosage of colchicine treatment is therefore generally adjusted according to clinical information and biochemical markers of subclinical inflammation. …
Metadata
Title
PW01-009 – Markers of inflammation in adult FMF patients
Authors
A Giese
H Wittkowski
A Örnek
M Kurucay
E Lainka
BF Henning
Publication date
01-11-2013
Publisher
BioMed Central
Published in
Pediatric Rheumatology / Issue Special Issue 1/2013
Electronic ISSN: 1546-0096
DOI
https://doi.org/10.1186/1546-0096-11-S1-A62

Other articles of this Special Issue 1/2013

Pediatric Rheumatology 1/2013 Go to the issue

Meeting abstract

PW01-020 – MEFV mutations carrier rate in Central Europe

Meeting abstract

PW02-017 - New tools for the ISSAID society website

Meeting abstract

P03-013 - Symptomatic neuromuscular sarcoidosis

Meeting abstract

OR2-001 – The possible role of pyrin on cell migration

Meeting abstract

P02-032 - CAPS: a novel mutation and an unusual phenotype

Meeting abstract

PW02-012 - First clinical description of an infant with DITRA